The appropriate action for a child with bronchiolitis is to admit them for supportive treatment, as antibiotics are not necessary. This condition is typically caused by RSV and can be managed with supportive care. However, if the child is experiencing severe respiratory distress and a significant reduction in feeding, they should be admitted to the hospital for treatment. Admitting for IV antibiotics would not be appropriate unless pneumonia or another bacterial infection was suspected. Salbutamol nebulisers are not typically effective for bronchiolitis. Discharging the child home with advice or oral antibiotics would not be appropriate if they are showing signs of potentially serious illness.

Bronchiolitis is a condition where the bronchioles become inflamed, and it is most commonly caused by respiratory syncytial virus (RSV). This virus is responsible for 75-80% of cases, with other causes including mycoplasma and adenoviruses. Bronchiolitis is most prevalent in infants under one year old, with 90% of cases occurring in those aged 1-9 months. The condition is more serious in premature babies, those with congenital heart disease or cystic fibrosis. Symptoms include coryzal symptoms, dry cough, increasing breathlessness, and wheezing. Hospital admission is often necessary due to feeding difficulties associated with increasing dyspnoea.

Immediate referral is recommended if the child has apnoea, looks seriously unwell, has severe respiratory distress, central cyanosis, or persistent oxygen saturation of less than 92% when breathing air. Clinicians should consider referral if the child has a respiratory rate of over 60 breaths/minute, difficulty with breastfeeding or inadequate oral fluid intake, or clinical dehydration. Immunofluorescence of nasopharyngeal secretions may show RSV, and management is largely supportive. Humidified oxygen is given via a head box if oxygen saturations are persistently low, and nasogastric feeding may be necessary if children cannot take enough fluid/feed by mouth. Suction may also be used for excessive upper airway secretions. NICE released guidelines on bronchiolitis in 2015 for more information.

Neonatal Sepsis: Causes, Risk Factors, and Management

Neonatal sepsis is a serious bacterial or viral infection in the blood that affects babies within the first 28 days of life. It is categorized into early-onset (EOS) and late-onset (LOS) sepsis, with each category having distinct causes and common presentations. The most common causes of neonatal sepsis are group B streptococcus (GBS) and Escherichia coli, accounting for approximately two-thirds of cases. Premature and low birth weight babies are at higher risk, as well as those born to mothers with GBS colonization or infection during pregnancy. Symptoms can vary from subtle signs of illness to clear septic shock, and diagnosis is usually established through blood culture. Treatment involves early identification and use of intravenous antibiotics, with duration depending on ongoing investigations and clinical picture. Other important management factors include maintaining adequate oxygenation and fluid and electrolyte status.

Neonatal Sepsis: Causes, Risk Factors, and Management

Neonatal sepsis is a serious infection that affects newborn babies within the first 28 days of life. It can be caused by a variety of bacteria and viruses, with GBS and E. coli being the most common. Premature and low birth weight babies, as well as those born to mothers with GBS colonization or infection during pregnancy, are at higher risk. Symptoms can range from subtle signs of illness to clear septic shock, and diagnosis is usually established through blood culture. Treatment involves early identification and use of intravenous antibiotics, with duration depending on ongoing investigations and clinical picture. Other important management factors include maintaining adequate oxygenation and fluid and electrolyte status.

Wolff-Parkinson-White syndrome is a condition that affects some patients and is caused by an additional electrical pathway between the atria and ventricles, leading to an irregular heart rate. If a mother takes lithium during the first trimester of pregnancy, it increases the risk of her child developing Ebstein’s anomaly.

Understanding Ebstein’s Anomaly

Ebstein’s anomaly is a type of congenital heart defect that is characterized by the tricuspid valve being inserted too low, resulting in a large atrium and a small ventricle. This condition is also known as the atrialization of the right ventricle. It is believed that exposure to lithium during pregnancy may cause this condition.

Ebstein’s anomaly is often associated with a patent foramen ovale (PFO) or atrial septal defect (ASD), which causes a shunt between the right and left atria. Additionally, patients with this condition may also have Wolff-Parkinson White syndrome.

The clinical features of Ebstein’s anomaly include cyanosis, a prominent a wave in the distended jugular venous pulse, hepatomegaly, tricuspid regurgitation, and a pansystolic murmur that is worse on inspiration. Patients may also have a right bundle branch block, which can lead to widely split S1 and S2 heart sounds.

In summary, Ebstein’s anomaly is a congenital heart defect that affects the tricuspid valve and can cause a range of symptoms. It is often associated with other conditions such as PFO or ASD and can be diagnosed through clinical examination and imaging tests.

Pregnant women between 16-32 weeks should be offered both influenzae and pertussis vaccines to protect the foetus and prevent the spread of pertussis. A hepatitis B booster is not necessary with either vaccine.

Whooping Cough: Causes, Symptoms, Diagnosis, and Management

Whooping cough, also known as pertussis, is a contagious disease caused by the bacterium Bordetella pertussis. It is commonly found in children, with around 1,000 cases reported annually in the UK. The disease is characterized by a persistent cough that can last up to 100 days, hence the name cough of 100 days.

Infants are particularly vulnerable to whooping cough, which is why routine immunization is recommended at 2, 3, 4 months, and 3-5 years. However, neither infection nor immunization provides lifelong protection, and adolescents and adults may still develop the disease.

Whooping cough has three phases: the catarrhal phase, the paroxysmal phase, and the convalescent phase. The catarrhal phase lasts around 1-2 weeks and presents symptoms similar to a viral upper respiratory tract infection. The paroxysmal phase is characterized by a severe cough that worsens at night and after feeding, and may be accompanied by vomiting and central cyanosis. The convalescent phase is when the cough subsides over weeks to months.

To diagnose whooping cough, a person must have an acute cough that has lasted for 14 days or more without another apparent cause, and have one or more of the following features: paroxysmal cough, inspiratory whoop, post-tussive vomiting, or undiagnosed apnoeic attacks in young infants. A nasal swab culture for Bordetella pertussis is used to confirm the diagnosis, although PCR and serology are increasingly used.

Infants under 6 months with suspected pertussis should be admitted, and in the UK, pertussis is a notifiable disease. An oral macrolide, such as clarithromycin, azithromycin, or erythromycin, is indicated if the onset of the cough is within the previous 21 days to eradicate the organism and reduce the spread. Household contacts should be offered antibiotic prophylaxis, although antibiotic therapy has not been shown to alter the course of the illness. School exclusion is recommended for 48 hours after commencing antibiotics or 21 days from onset of symptoms if no antibiotics are given.

Complications of whooping cough include subconjunctival haemorrhage, pneumonia, bronchiectasis, and

Children who have Down’s syndrome are susceptible to snoring due to their low muscle tone in the upper airways, large tongue/adenoids, and increased risk of obesity. On the other hand, gastroesophageal reflux disease is not connected to snoring, but it can worsen at night and cause coughing. Tonsillectomy is a common treatment for snoring as it eliminates enlarged tonsils that can obstruct the upper airway. Hypothyroidism, not hyperthyroidism, is linked to snoring.

Snoring in Children: Possible Causes

Snoring in children can be caused by various factors. One of the common causes is obesity, which can lead to the narrowing of the airways and difficulty in breathing during sleep. Another possible cause is nasal problems such as polyps, deviated septum, and hypertrophic nasal turbinates, which can also obstruct the airways and cause snoring. Recurrent tonsillitis can also contribute to snoring, as the inflamed tonsils can block the air passages.

In some cases, snoring in children may be associated with certain medical conditions such as Down’s syndrome and hypothyroidism. These conditions can affect the structure and function of the respiratory system, leading to snoring and other breathing difficulties.

It is important to identify the underlying cause of snoring in children and seek appropriate treatment to prevent potential health complications. Parents should consult a healthcare professional if their child snores regularly or experiences other symptoms such as daytime sleepiness, difficulty concentrating, or behavioral problems.

Exclusion from a childcare setting or school is not necessary for a child with hand, foot and mouth disease, as long as they are feeling well.

Hand, Foot and Mouth Disease: A Contagious Condition in Children

Hand, foot and mouth disease is a viral infection that commonly affects children. It is caused by intestinal viruses from the Picornaviridae family, particularly coxsackie A16 and enterovirus 71. This condition is highly contagious and often occurs in outbreaks in nurseries. The symptoms of hand, foot and mouth disease include mild systemic upset such as sore throat and fever, as well as oral ulcers and vesicles on the palms and soles of the feet.

Symptomatic treatment is the only management option for hand, foot and mouth disease. This includes general advice about hydration and analgesia, as well as reassurance that there is no link to disease in cattle. Children do not need to be excluded from school, but the Health Protection Agency recommends that children who are unwell should be kept off school until they feel better. If there is a suspected large outbreak, it is advised to contact the Health Protection Agency for further guidance.

Dilated cardiomyopathy is the most common heart condition linked to Duchenne muscular dystrophy, while acute myocardial infarctions, atrioventricular septal defects, and coronary aneurysms are not associated with this condition. Atrioventricular septal defects are, however, associated with Down syndrome, while coronary aneurysms are a complication of Kawasaki disease. Dilated cardiomyopathy is a rapidly progressive complication that typically starts in adolescence for individuals with Duchenne muscular dystrophy, an X-linked recessive condition characterized by progressive muscle wasting and weakness.

Understanding Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is a genetic disorder that is inherited in an X-linked recessive manner. It affects the dystrophin genes that are essential for normal muscular function. The disorder is characterized by progressive proximal muscle weakness that typically begins around the age of 5 years. Other features include calf pseudohypertrophy and Gower’s sign, which is when a child uses their arms to stand up from a squatted position. Approximately 30% of patients with Duchenne muscular dystrophy also have intellectual impairment.

To diagnose Duchenne muscular dystrophy, doctors typically look for elevated levels of creatinine kinase in the blood. However, genetic testing has now replaced muscle biopsy as the preferred method for obtaining a definitive diagnosis. Unfortunately, there is currently no effective treatment for Duchenne muscular dystrophy, so management is largely supportive.

The prognosis for Duchenne muscular dystrophy is poor. Most children with the disorder are unable to walk by the age of 12 years, and patients typically survive to around the age of 25-30 years. Duchenne muscular dystrophy is also associated with dilated cardiomyopathy, which can further complicate the management of the disorder.

When a slipped upper femoral epiphysis (SCFE) occurs, it is crucial to seek immediate medical attention as there is a risk of avascular necrosis of the femoral head. Referral to paediatric orthopaedics is necessary, and the child should not bear weight and should be given pain relief to ensure comfort. The most effective treatment for SCFE is internal fixation surgery, which prevents the slip from worsening. The Ponseti method, which involves a series of manipulations and casts over several weeks, is typically used to treat clubfoot.

Slipped Capital Femoral Epiphysis: A Rare Hip Condition in Children

Slipped capital femoral epiphysis, also known as slipped upper femoral epiphysis, is a rare hip condition that primarily affects children between the ages of 10 and 15. It is more commonly seen in obese boys. This condition is characterized by the displacement of the femoral head epiphysis postero-inferiorly, which may present acutely following trauma or with chronic, persistent symptoms.

The most common symptoms of slipped capital femoral epiphysis include hip, groin, medial thigh, or knee pain and loss of internal rotation of the leg in flexion. In some cases, a bilateral slip may occur. Diagnostic imaging, such as AP and lateral (typically frog-leg) views, can confirm the diagnosis.

The management of slipped capital femoral epiphysis typically involves internal fixation, which involves placing a single cannulated screw in the center of the epiphysis. However, if left untreated, this condition can lead to complications such as osteoarthritis, avascular necrosis of the femoral head, chondrolysis, and leg length discrepancy.

In summary, slipped capital femoral epiphysis is a rare hip condition that primarily affects children, especially obese boys. It is characterized by the displacement of the femoral head epiphysis postero-inferiorly and can present with various symptoms. Early diagnosis and management are crucial to prevent complications.

For infants to be considered healthy, their respiratory rate should fall within the range of 30-60 breaths per minute. Additionally, their pulse should be regular and fall between 100-160 beats per minute for newborns. Their body temperature should be around 37 Celsius, and they should have regular bowel movements and urination.

Child Health Surveillance in the UK

Child health surveillance in the UK involves a series of checks and tests to ensure the well-being of children from before birth to preschool age. During the antenatal period, healthcare professionals ensure that the baby is growing properly and check for any maternal infections that may affect the baby. An ultrasound scan is also performed to detect any fetal abnormalities, and blood tests are done to check for neural tube defects.

After birth, a clinical examination of the newborn is conducted, and a hearing screening test is performed. The mother is given a Personal Child Health Record, which contains important information about the child’s health. Within the first month, a heel-prick test is done to check for hypothyroidism, PKU, metabolic diseases, cystic fibrosis, and medium-chain acyl Co-A dehydrogenase deficiency (MCADD). A midwife visit may also be conducted within the first four weeks.

In the following months, health visitor input is provided, and a GP examination is done at 6-8 weeks. Routine immunisations are also given during this time. Ongoing monitoring of growth, vision, and hearing is conducted, and health professionals provide advice on immunisations, diet, and accident prevention.

In preschool, a national orthoptist-led programme for preschool vision screening is set to be introduced. Overall, child health surveillance in the UK aims to ensure that children receive the necessary care and attention to promote their health and well-being.

Referral or admission is not necessary for this straightforward primary care case, which can be treated with topical antibiotics (with the addition of oral antibiotics containing fusidic acid if resistance is suspected or confirmed). However, it is important to advise the patient that they should not return to school or attend their school trip until 48 hours after starting antibiotic treatment or until the lesions have crusted and healed.

The Health Protection Agency has provided guidance on when children should be excluded from school due to infectious conditions. Some conditions, such as conjunctivitis, fifth disease, roseola, infectious mononucleosis, head lice, threadworms, and hand, foot and mouth, do not require exclusion. Scarlet fever requires exclusion for 24 hours after commencing antibiotics, while whooping cough requires exclusion for 2 days after commencing antibiotics or 21 days from onset of symptoms if no antibiotics are taken. Measles requires exclusion for 4 days from onset of rash, rubella for 5 days from onset of rash, and chickenpox until all lesions are crusted over. Mumps requires exclusion for 5 days from onset of swollen glands, while diarrhoea and vomiting require exclusion until symptoms have settled for 48 hours. Impetigo requires exclusion until lesions are crusted and healed, or for 48 hours after commencing antibiotic treatment, and scabies requires exclusion until treated. influenzae requires exclusion until the child has recovered. The official advice regarding school exclusion for chickenpox has varied, but the most recent guidance suggests that all lesions should be crusted over before children return to school.